✦ LIBER ✦

Quantifying cancer progression with conjunctive Bayesian networks

✍ Scribed by Gerstung, M.; Baudis, M.; Moch, H.; Beerenwinkel, N.

Book ID: 111676617
Publisher: Oxford University Press
Year: 2009
Tongue: English
Weight: 336 KB
Volume: 25
Category: Article
ISSN: 1367-4803
DOI: 10.1093/bioinformatics/btp505

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathways of urothelial cancer progressio

Pathways of urothelial cancer progression suggested by Bayesian network analysis of allelotyping data

✍ Svetlana Bulashevska; Orsolya Szakacs; Benedikt Brors; Roland Eils; Gyula Kovacs 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB

## Abstract Urothelial cancers of the bladder (UC) comprise biologically heterogeneous group of tumors and display complex genetic alterations. Several genetic changes have been analyzed in detail and some of them are associated with the development and progression of UCs. Only a few studies, howev

A Bayesian Random-Effects Markov Model f

A Bayesian Random-Effects Markov Model for Tumor Progression in Women with a Family History of Breast Cancer

✍ Grace Hui-Min Wu; Shu-Hui Chang; Tony Hsiu-Hsi Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

A Bayesian ensemble approach with a dise

A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers

✍ Won, Hong-Hee; Kim, Jong-Won; Lee, Doheon 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 725 KB

A Bayesian neural network approach for m

A Bayesian neural network approach for modelling censored data with an application to prognosis after surgery for breast cancer

✍ P.J.G. Lisboa; H. Wong; P. Harris; R. Swindell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 918 KB

The Sex-Determining Region Y-Box 4 and H

The Sex-Determining Region Y-Box 4 and Homeobox C6 Transcriptional Networks in Prostate Cancer Progression: Crosstalk with the Wnt, Notch, and PI3K Pathways

✍ Carlos S. Moreno 📂 Article 📅 2010 🏛 American Society for Investigative Pathology 🌐 English ⚖ 726 KB

Progression-Free Survival with Fulvestra

Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer: A Network Meta-Analysis with Parametric Survival Models

✍ Cope, Shannon; Ouwens, Mario J.N.M.; Jansen, Jeroen P.; Schmid, Peter 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 928 KB